COVID-19 vaccine recipients continues to draw significant attention, but experts maintain the event is exceedingly rare — and treatable, in most cases.Vaccine-induced thrombotic thrombocytopenia, or VITT, has been identified in at least 18 Oxford-AstraZeneca recipients in Canada, with 10 more under review.
There have been three deaths associated with the condition. A look at who the provinces plan to vaccinate against COVID-19 in the coming weeks The disorder, characterized by low platelet counts, has been associated with but not definitively linked to the viral vector shots from AstraZeneca and Johnson & Johnson.Some provinces have started to move away from using AstraZeneca for first doses.